Evidence map›Paper›PMID 38250317›Full record

ArticleTherapeutic advances in neurological disorders2024

Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia.

Yingying Zhang, Jiechuan Ren, Tianhua Yang, Weixi Xiong, Linyuan Qin, Dongmei An, Fayun Hu, Dong Zhou

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in neurological disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Rare Movement Disorders-An Approach for Clinicians.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yingying ZhangDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Jiechuan RenDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Tianhua YangDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Weixi XiongDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Linyuan QinDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Dongmei AnDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Fayun HuDepartment of Neurology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan 610041, China.
Dong ZhouDepartment of Neurology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan 610041, China.ORCID https://orcid.org/0000-0001-7101-4125
Sichuan University · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Paroxysmal kinesigenic dyskinesia (PKD) is a rare neurological disorder, characterized by attacks of involuntary movements triggered by sudden action. Variants in proline-rich transmembrane protein 2 ( Objective: The objective was to investigate the clinical and genetic characteristics of PKD and to establish genotype-phenotype correlations. Methods: We enrolled 219 PKD patients, documented their clinical information and performed Results: Among 219 PKD patients (99 cases from 39 families and 120 sporadic cases), 16 Conclusion: These findings provide insights on the clinical characteristics, diagnostic timeline and treatment response of PKD patients. PKD patients with truncated

Indexed as

carbamazepinegenotype–phenotype correlationsoxcarbazepineparoxysmal kinesigenic dyskinesiaPRRT2

Identifiers

PMID38250317
PMCPMC10798112
OpenAlexW4390989583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.